SCOPUS 정보 검색 플랫폼

Neurology

Volumn 64, Issue 7, 2005, Pages 1270-1272

An open label study of the effects of rituximab in neuromyelitis optica

(6) Cree, Bruce A C a,b Lamb, S a Morgan, K a Chen, A a Waubant, E a Genain, C a

a UNIVERSITY OF CALIFORNIA (United States)

b UCSF Multiple Sclerosis Center (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; BETA INTERFERON; GLATIRAMER; METHYLPREDNISOLONE; MITOXANTRONE; RITUXIMAB;

ADULT; ARTICLE; B LYMPHOCYTE; CHILL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFECT; DRUG TOLERABILITY; EXPANDED DISABILITY STATUS SCALE; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; LYMPHOCYTE DEPLETION; MALE; MYELOOPTIC NEUROPATHY; NEUROLOGIC EXAMINATION; OPEN STUDY; PLASMAPHERESIS; PRIORITY JOURNAL; RELAPSE; SIDE EFFECT; SINUSITIS; TREATMENT OUTCOME;

EID: 16844366404 PISSN: 00283878 EISSN: None Source Type: Journal
DOI: 10.1212/01.WNL.0000159399.81861.D5 Document Type: Article

Times cited : (590)

References (7)

1
- 0036625778
- Neuromyelitis optica
- Cree BA, Goodin DS, Hauser SL. Neuromyelitis optica. Semin Neurol 2002;22:105-122.
- (2002) Semin Neurol , vol.22 , pp. 105-122
- Cree, B.A.¹ Goodin, D.S.² Hauser, S.L.³

2
- 0037039226
- Plasma exchange for severe attacks of CNS demyelination: Predictors of response
- Keegan M, Pineda AA, McClelland RL, Darby CH, Rodriguez M, Weinshenker BG. Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology 2002;58:143-146.
- (2002) Neurology , vol.58 , pp. 143-146
- Keegan, M.¹ Pineda, A.A.² McClelland, R.L.³ Darby, C.H.⁴ Rodriguez, M.⁵ Weinshenker, B.G.⁶

3
- 0031665071
- Devic's neuromyelitis optica: A prospective study of seven patients treated with prednisone and azathioprine
- Mandler RN, Ahmed W, Dencoff JE. Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology 1998;51:1219-1220.
- (1998) Neurology , vol.51 , pp. 1219-1220
- Mandler, R.N.¹ Ahmed, W.² Dencoff, J.E.³

4
- 0036310181
- A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica
- Lucchinetti CF, Mandler RN, McGavern D, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2002;125:1450-1461.
- (2002) Brain , vol.125 , pp. 1450-1461
- Lucchinetti, C.F.¹ Mandler, R.N.² McGavern, D.³

5
- 10344250945
- A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis
- Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004;364:2106-2112.
- (2004) Lancet , vol.364 , pp. 2106-2112
- Lennon, V.A.¹ Wingerchuk, D.M.² Kryzer, T.J.³

6
- 0033595449
- The clinical course of neuromyelitis optica (Devic's syndrome)
- Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999;53:1107-1114.
- (1999) Neurology , vol.53 , pp. 1107-1114
- Wingerchuk, D.M.¹ Hogancamp, W.F.² O'Brien, P.C.³ Weinshenker, B.G.⁴

7
- 0021035886
- Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
- Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-1452.
- (1983) Neurology , vol.33 , pp. 1444-1452
- Kurtzke, J.F.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.